The convergence of clinical and biomarker effects in a biomarker enriched subgroup in the Phase II ALS dataset with AP-101 is ...

Peru's electoral landscape sees unprecedented fragmentation and a voter base that appears to be turning away from the ...

What if gene editing could be designed as precisely as a race car tuned to a specific track?With new funding from Genome Canada and Ontario Genomics ...

BlossomHill Therapeutics, Inc., a privately-held, clinical-stage biopharmaceutical company focused on the design and development of next-generation medicines for cancer, today announced it will ...

Clinically meaningful activity was observed in 57 patients at 400 mg BID fed, including 11.1-month median PFS and mutation-subtype–agnostic benefit across kinase versus nonkinase PIK3CA variants.

Amphista Therapeutics (“the Company” or “Amphista”), a leader in the discovery and development of non-cereblon/non-VHL Targeted Glue™ degraders, today announces three upcoming presentations at the ...

Actor Kevin Spacey has settled out of court in England with three men who sued him, accusing him of sexual assault.

Positive interim Phase 1 data of NEK7-directed MGD MRT-8102 demonstrated profound CRP reductions in elevated CVD-risk subjects; readout of ...

Explore 6 Maryland biotech companies with recent funding, ready to bring their breakthrough technologies to the clinic.

Detailed price information for Sellas Life Sciences Group Inc (SLS-Q) from The Globe and Mail including charting and trades.

The late Steve Jobs’s son set up a VC firm that backs startups and researchers working on cancer treatments. Now his Yosemite ...

Positive interim Phase 1 data of NEK7-directed MGD MRT-8102 demonstrated profound CRP reductions in elevated CVD-risk subjects; readout of expanded part 3 CRP PoC trial (now called GFORCE-1) anticipat ...